Pain intensity VAS (0 to 100; 0 = no pain, 100 = worst pain) · women in labour with planned vaginal delivery
1 finding from 1 review
Hypertensive disorders of pregnancy: pre‐eclampsia · women with gestational diabetes mellitus
Insulin showed no clear difference in hypertensive disorders of pregnancy (pre‐eclampsia) compared with anti‐diabetic agent (moderate certainty).
1 finding from 1 review
Hypertensive disorders of pregnancy · women with gestational diabetes mellitus
Insulin probably leads to higher hypertensive disorders of pregnancy (not defined) compared with anti‐diabetic agent (moderate certainty).
1 finding from 1 review
Participant‐reported pain intensity VAS (0‐10, lower score = less pain) · adults with neuropathic pain
1 finding from 1 review
Participant‐reported pain intensity VAS (0‐10, lower score = less pain) · adults with neuropathic pain
1 finding from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · adults with neuropathic pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · adults with neuropathic pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Incidence of severe maternal infectious morbidity · Women who had normal vaginal births
1 finding from 1 review
Hypertensive disorders of pregnancy: pre‐eclampsia · women with gestational diabetes mellitus
Exercise showed no clear difference in hypertensive disorders of pregnancy (pre‐eclampsia) compared with control (low certainty).
1 finding from 1 review
Intervention not reported
Mean pain intensity at end of study · people with cancer pain
1 finding from 1 review
Pain intensity (0‐10cm visual analogue scale) · patients with fibromyalgia
1 finding from 1 review
Adverse events: hypotension · Patients receiving radiotherapy on its own or in addition to chemotherapy to the head and neck region
Amifostine may leads to higher hypotension (adverse effect) compared with no treatment/placebo (low certainty).
1 finding from 1 review
Relief of burning/discomfort (symptom relief; pain intensity) · People with primary burning mouth syndrome (BMS), that is, oral mucosal pain with no dental or medical cause for such symptoms
1 finding from 1 review
Interventions for treating burning mouth syndrome 2016 · Cochrane All outcomesshort-term (up to 3 months)
SoF5 Dietary supplements vs placebo. Symptom relief short-term: insufficient or contradictory evidence regarding benefit of any evaluated dietary supplement; 628 participants (12 RCTs); very low. Subgroups: ALA without…
12 studies · 628 participants
Very low
Relief of burning/discomfort (symptom relief; pain intensity) · People with primary burning mouth syndrome (BMS), that is, oral mucosal pain with no dental or medical cause for such symptoms
1 finding from 1 review
Interventions for treating burning mouth syndrome 2016 · Cochrane All outcomesshort-term (up to 3 months) · benzydamine hydrochloride
SoF9 Topical treatments vs placebo. Symptom relief short-term: insufficient or contradictory evidence regarding benefit of any evaluated topical treatment; 150 participants (4 RCTs); very low. Subgroups: benzydamine (1…
4 studies · 150 participants
Very low
Relief of burning/discomfort (symptom relief; pain intensity) · People with primary burning mouth syndrome (BMS), that is, oral mucosal pain with no dental or medical cause for such symptoms
It is very uncertain whether benzodiazepines (topical clonazepam) changes relief of burning/discomfort (symptom relief; pain intensity) compared with placebo (very low certainty).
2 findings from 1 review
Relief of burning/discomfort (symptom relief; pain intensity) · People with primary burning mouth syndrome (BMS), that is, oral mucosal pain with no dental or medical cause for such symptoms
It is very uncertain whether anticonvulsants (gabapentin 300 mg/day, +/- alpha lipoic acid) changes relief of burning/discomfort (symptom relief; pain intensity) compared with placebo (very low certainty).
1 finding from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · Adults undergoing orthodontic treatment
Cognitive behavioural therapy (CBT) led to lower patient‐reported pain intensity or pain relief (VAS, NRS or… compared with no special instructions (control); GRADE not reported.
3 findings from 1 review
MD -27.91 [-40.10, -15.72]
1 study · 24 participants
GRADE not reported
MD -6.50 [-17.64, 4.64]
1 study · 24 participants
GRADE not reported
MD -20.67 [-32.12, -9.22]
1 study · 24 participants
Very low
Relief of burning/discomfort (symptom relief; pain intensity) · People with primary burning mouth syndrome (BMS), that is, oral mucosal pain with no dental or medical cause for such symptoms
It is very uncertain whether electromagnetic radiation (low-level laser therapy) changes relief of burning/discomfort (symptom relief; pain intensity) compared with placebo (very low certainty).
1 finding from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · Adolescents and adults undergoing orthodontic treatment
Low‐level laser therapy (LLLT) showed no clear difference in patient‐reported pain intensity or pain relief (VAS, NRS or… compared with placebo (or no irradiation); GRADE not reported.
5 findings from 1 review
MD -10.63 [-22.33, 1.07]
2 studies · 118 participants
GRADE not reported
MD -6.39 [-8.65, -4.13]
1 study · 58 participants
GRADE not reported
Two further studies (160 participants) used bespoke assessments. Harazaki 1997 (84 participants): slightly lower proportion reporting severe pain in the intervention group, no inferential statistics. Turhani 2006 (76…
2 studies · 160 participants
GRADE not reported
Show 2 more findings
MD -10.76 [-13.80, -7.73]
2 studies · 118 participants
GRADE not reported
MD -20.27 [-24.50, -16.04]
2 studies · 118 participants
Low
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · Adolescents/teenagers undergoing orthodontic treatment
Experimental chewing adjuncts (bite wafers or chewing gum) showed no clear difference in patient‐reported pain intensity or pain relief (VAS, NRS or… compared with no chewing gum, placebo, or control (no adjunct); GRADE not reported.
5 findings from 1 review
MD -1.39 [-3.24, 0.64]
1 study · 39 participants
GRADE not reported
MD -29.16 [-51.67, -6.65]
1 study · 39 participants
GRADE not reported
MD -15.17 [-32.44, 2.11]
2 studies · 96 participants
GRADE not reported
Show 2 more findings
MD -15.38 [-28.90, -1.86]
2 studies · 96 participants
Very low
Non‐pharmacological interventions for alleviating pain during orthodontic treatment 2016 · Cochrane All outcomes1 day · Bite wafer subgroup (median data, opposite direction)
Otasevic 2006 (84 participants) presented median values only and reported higher median pain in the bite wafer group than the group who avoided chewing at one day (P = 0.006); data not suitable for meta‐analysis.
1 study · 84 participants
GRADE not reported